Company or ticker...

Health

Delcath Systems

Delcath Systems develops and sells a targeted liver cancer treatment system that delivers high doses of chemotherapy directly to the liver while filtering the drug from the blood.

Ticker

M. Cap

PS

PE

YTD

10MA

20MA

50MA

200MA

DCTH

752.4M

5.3

3,581.8

115.89%

Key Facts

M. Cap

PS

PE

YTD

752.4M

5.3

3,581.8

115.89%

10MA

20MA

50MA

200MA

$DCTH